Asymmetric Targeted DBS for PD With PIGD
Trial
N/A
Unknown
Jan. 22, 2023
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
Trial
Phase 3
Terminated
Jan. 19, 2023
Parkinson's Disease G2019S LRRK2 Genetic Testing Program
Trial
N/A
Terminated
Jan. 17, 2023
Gondola Mechanism of Action
Trial
N/A
Withdrawn
Jan. 17, 2023
A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease
Trial
N/A
Terminated
Jan. 17, 2023
Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers
Trial
Phase 1
Completed
Jan. 10, 2023
Monitoring Movement Disorder Symptoms With a Mobile Medical App on Off-the-shelf Consumer Mobile Devices
Trial
N/A
Unknown
Jan. 10, 2023
Study of Motor Control Mechanisms in DBS-implanted Parkinson's Disease Patients
Trial
N/A
Terminated
Jan. 9, 2023
Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
Trial
Phase 1
Completed
Jan. 9, 2023
High Frequency and Intensive Prevention Program
Trial
N/A
Completed
Jan. 5, 2023
Varenicline for Gait and Balance Impairment in Parkinson Disease
Trial
Phase 2
Completed
Dec. 29, 2022
Methylphenidate for Apathy in Veterans With Parkinson's Disease
Trial
Phase 2
Not yet recruiting
Dec. 29, 2022
Validation of Dyskinesia Rating Scales
Trial
Phase 4
Completed
Dec. 28, 2022
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Trial
Phase 4
Completed
Dec. 28, 2022
Femoral Cartilage Thickness in Parkinson's Disease
Trial
N/A
Completed
Dec. 26, 2022
Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease
Trial
N/A
Terminated
Dec. 26, 2022
Evaluation of Clinical Progression in Patients With Motor Predominant Parkinson Disease.
Trial
N/A
Terminated
Dec. 20, 2022
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Trial
Phase 3
Completed
Dec. 15, 2022